Oregon Completes First Full Year of Psilocybin Services Data Collection

SALEM – Oregon Psilocybin Services (OPS) has wrapped up its 2025 quarterly reporting, giving the public its clearest view yet of how the state’s regulated program performed over a full calendar year. Psychedelic Alpha released its summary of the Q4 data, drawing from official state dashboards to highlight trends in client numbers, session formats, safety records, and who is actually using the services.

Since OPS launched in January 2023, an estimated 16,000 clients have received psilocybin sessions, driving the sale of over 37,000 psilocybin products and generating more than $1.7 million in revenue. That demand has been consistent. What has changed is pricing. The average price per product has declined each year, falling from roughly $85 in 2023 to an estimated $50 by mid-2026 – a trend that likely reflects increased competition as more licensed manufacturers enter the market.

The full-year figures show 5,935 clients received services across 5,375 administration sessions in 2025. Individual sessions made up the majority, with 4,628 recorded, while 747 group sessions served an average of about three clients each. Session volume peaked earlier in the year, with Q1 and Q2 each seeing around 1,400 sessions. Numbers fell below 1,000 in Q3 and Q4. Group sessions held steadier, increasing their share of total administrations to over 16% by the final quarter.

Product sales and client motivations followed consistent patterns. Many participants cited wellness, self-exploration, creativity, and mental health support as reasons for seeking services, with the ability to select multiple options. The average client age across the first three quarters of 2025 was 46, with approximately 20% of clients above 60. Racial and ethnic demographics showed limited diversity, with Western European and White identities forming the largest groups. English remained the dominant preferred language.

Only 23 of the 35 licensed psilocybin service centers remain operational, marking the closure of 12 centers since early 2024, with reports of a further closure planned for the end of January 2026. A key driver appears to be high operational costs, including a $10,000 annual license fee, mandated security infrastructure, and stringent storage protocols.

Facilitator numbers have continued their year-on-year rise, with 366 currently licensed or approved, yet many are struggling to secure full-time employment within OPS, a challenge compounded by 2025 legislation prohibiting facilitators from offering psilocybin services outside regulated settings. Training program costs typically range from $4,500 to $12,000, with practicum components adding further expense. Annual licensure fees run between $1,000 and $2,000, meaning first-year costs can easily exceed $10,000 for new facilitators.

Oregon’s psilocybin program remains the most data-rich regulated psychedelic services framework in the United States, and each quarterly release adds another layer of operational transparency that other emerging markets will eventually need to match. The Q4 2025 data confirms that the fundamentals (demand, safety record, and licensing continuity) are holding. What the program has yet to fully solve is the affordability ceiling and the equity gap it creates.

As the Psychedelic Alpha Oregon Psilocybin Services Tracker continues to build out its time-series dataset, the clearest signal for investors and policymakers alike is this: a market can be pioneering and undersupported at the same time. Oregon has proven the concept works.